The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

From 1999 to 2022, there was a considerable increase in maternal mortality due to cardiovascular disease (CVD).

Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

Maternal influences have a persistent effect on offspring obesity through age 42 years, according to a study published online.

Microplastic exposure may increase the risk for chronic diseases, according to a study presented at the annual meeting of the American College of Cardiology.

Engaging in physical activity concentrated within 1 to 2 days is associated with a similar reduction in mortality risk as active regular physical activity.

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

The relationship between depressive symptoms and physical activity in knee osteoarthritis (OA) may vary over time, with initial — but not significant — overall reductions followed by nonlinear ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.

Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online.

Long-term glucocorticoid (GC) use among older adults with late-onset rheumatoid arthritis (LORA) remains prevalent, despite its known adverse effects, according to study results published in ACR Open ...